Company Filing History:
1 out of 2,078 
1 out of 61 
Years Active: 2024-2025
Title: The Innovations of Kristof Leonard Kimpe
Introduction
Kristof Leonard Kimpe is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical treatments. With a total of 2 patents to his name, Kimpe's work is recognized for its potential impact on healthcare.
Latest Patents
Kimpe's latest patents include a crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate. This invention relates to a crystalline form of Compound A, which is useful in the treatment of MALT-1 related diseases. Another significant patent is for the hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2-imidazo[4,5-C]pyridin-2-one. This compound, also known as rilematovir, serves as an RSV fusion inhibitor and is crucial in pharmaceutical compositions.
Career Highlights
Throughout his career, Kimpe has worked with prominent companies such as Janssen Pharmaceutica and Janssen Sciences Ireland Unlimited Company. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical science.
Collaborations
Some of Kimpe's notable coworkers include Carina Leys and Robert Michael Geertman. Their collaborative efforts have played a role in the successful development of his patented inventions.
Conclusion
Kristof Leonard Kimpe's contributions to the field of pharmaceuticals through his innovative patents highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, showcasing the impact of dedicated research and collaboration.